Back to Invesco Ltd. Invesco Ltd.

REGNREGN
Showing 8 of 23 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in REGENERON PHARMACEUTICALS

Invesco Ltd. holds 3.9M shares of REGN (REGENERON PHARMACEUTICALS), worth $2.5B as of 2026-Q2. The position was increased (+0.9% shares). REGN represents 0.2% of Invesco Ltd.'s portfolio.

Current Value

$2.5B

Current Shares

3.9M

Total Value Change

+$1.2B

Total Shares Change

+2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.9M
+0.9%
$2.5B0.2%$622.81
38
2026-Q1
Decreased
3.9M
-0.2%
$3B0.3%$770.59
0
2025-Q4
Increased
3.9M
+163.5%
$3B0.3%$768.90
62
2025-Q3
Increased
1.5M
+38.0%
$834.7M0.1%$559.40
50
2025-Q2
Increased
1.1M
+26.5%
$564.8M0.1%$521.53
39
2025-Q1
Decreased
850,746
-1.6%
$539.6M0.1%$629.11
0
2024-Q4
Decreased
864,249
-25.6%
$615.6M0.1%$705.67
0
2024-Q3
Increased
1.2M
+26.7%
$1.2B0.2%$1,041.41
47

Other major holders of REGN: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used